Biological Variation of N-Terminal Pro-Brain Natriuretic Peptide in Healthy Individuals
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Brain natriuretic peptide (BNP) and its N-terminal prohormone (NT-proBNP) fragment have been shown to be effective in diagnosing left ventricular dysfunction (1)(2), and in particular, they have a strong negative predictive value (3). NT-proBNP and the hormone are secreted on an equimolar basis, but NT-proBNP lacks a clearance receptor. It therefore has a longer half-life in serum than the active hormone does, and its circulating concentration is believed to be less influenced by the conditions under which the blood sample is taken. Information on the biological variation of NT-proBNP is not available; this is limiting because the clinical utility of laboratory data can be affected by physiologic variation (4). Here we report the results of a study to determine the biological variability of NT-proBNP. Five blood specimens were collected from each of 16 apparently healthy laboratory workers (5 men and 11 women; age range, 43–62 years) twice a week (Tuesdays and Fridays) over a 17-day period. None of the workers smoked, took any medication, or consumed substantial quantities of alcohol. In accordance with Helsinki Declaration II, the design and execution of the experiment were explained thoroughly to the participants, and informed consent was obtained. Blood was collected under standardized conditions to minimize sources of preanalytic variation. After an overnight fast, a blood specimen was taken by conventional venipuncture between 0800 and 0900 with the volunteers in the sitting position, avoiding venous stasis. All samples were drawn by the same phlebotomist, allowed to clot, and then centrifuged at 3000g for 15 min at room temperature within 1 h of collection. Sera were separated and stored at −70 °C until analysis. It has been documented that the N-terminal peptide can be safely stored frozen at −20 and −80 °C for at least 3 months (5). At the end of the collection period, all frozen samples were thawed, mixed, and centrifuged for analysis in a single run in duplicate. NT-proBNP concentrations were determined by an electrochemiluminescence sandwich immunoassay (Roche Diagnostics). The assay was performed on an Elecsys System 2010 by the same analyst, who followed the assay manufacturer’s recommendations. After exclusion of one outlier and logarithmic transformation of the data (required because of the skewed distributions of the NT-proBNP data), the analytical (CVA) and intra- (CVI) and interindividual (CVG) components of variation were calculated by nested ANOVA. We also calculated the critical difference for significant changes in serial results (P <0.05), the index of individuality, the number of specimens required to estimate the homeostatic setpoint of an individual (within ± 10% with a confidence of 95%), and the desirable quality specifications for imprecision (I), bias (B), and total error (TE), which were calculated using the formulas: I < 0.5CVI; B < 0.25 (CVI2 + CVG2)1/2; and TE < 1.65 I + B (α <0.05). The results are reported in Table 1 . Mean values; estimated mean analytical (CVA), intraindividual (CVI), and interindividual (CVG) variation; and derived indices for serum NT-proBNP. II, index of individuality; CD, critical difference. Mean values; estimated mean analytical (CVA), intraindividual (CVI), and interindividual (CVG) variation; and derived indices for serum NT-proBNP. II, index of individuality; CD, critical difference. Minor, not statistically significant differences (P = 0.87), were observed between genders and were attributable to the lower CVI in the men. The quality specifications for assay imprecision (CVA < 0.5CVI) were widely fulfilled. The individuality index was close to 0.6, indicating that an individual’s results are more useful as reference values than are population-based data when the results are used in monitoring. Finally, serial results for pro-BNP must change by >26% before significance can be claimed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Higashi, Y., Yoshioka, H., Yamane, M., Gotoh, O., & Fujii-Kuriyama, Y. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.2841 · Cited by 555
A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency
Schalkwijk, J., Zweers, M. C., Steijlen, P. M., Dean, W. B., Taylor, G., van Vlijmen, I. M., van Haren, B., Miller, W. L., & Bristow, J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa002939 · Cited by 391
Tenascin-X deficiency is associated with Ehlers-Danlos syndrome
Burch, G. H., Gong, Y., Liu, W., Dettman, R. W., Curry, C. J., Smith, L., Miller, W. L., & Bristow, J. (1997) · Nature Genetics · doi:10.1038/ng0997-104 · Cited by 366
Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B
Bristow, J., Tee, M., Gitelman, S., Mellon, S., & Miller, W. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.265 · Cited by 302
Cited by
Palladini, G., Dispenzieri, A., Gertz, M. A., Kumar, S., Wechalekar, A., Hawkins, P. N., Schönland, S., Hegenbart, U., Comenzo, R., Kastritis, E., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.7614 · Cited by 974
Self-citationPalladini, G., Lavatelli, F., Russo, P., Perlini, S., Perfetti, V., Bosoni, T., Obici, L., Bradwell, A. R., D'Eril, G. M., Fogari, R., et al. (2006) · Blood · doi:10.1182/blood-2005-11-4385 · Cited by 311
Self-citationWilson Tang, W. H., Francis, G. S., Morrow, D. A., Newby, L. K., Cannon, C. P., Jesse, R. L., Storrow, A. B., Christenson, R. H., COMMITTEE MEMBERS, Christenson, R. H., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.185267 · Cited by 310
Variability of biomarkers in patients with chronic heart failure and healthy controls
Meijers, W. C., van der Velde, A. R., Muller Kobold, A. C., Dijck-Brouwer, J., Wu, A. H., Jaffe, A., & de Boer, R. A. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.669 · Cited by 146
Wu, A. H. B. (2013) · Current Heart Failure Reports · doi:10.1007/s11897-013-0156-6 · Cited by 45
Metadata
- Authors
- Melzi d’Eril, G., Tagnochetti, T., Nauti, A., Klersy, C., Papalia, A., Vadacca, G., Moratti, R., & Merlini, G.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-09-01
- Volume
- 49
- Issue
- 9
- Pages
- 1554-1555
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2102555736
- Cited by
- 59
- References
- 4
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biological Variation of N-Terminal Pro-Brain Natriuretic Peptide in Healthy Individuals. https://app.cochat.ai/papers/10.1373/49.9.1554
- The paper
- Melzi d’Eril, G., Tagnochetti, T., Nauti, A., Klersy, C., Papalia, A., Vadacca, G., Moratti, R., & Merlini, G. (2003). Biological Variation of N-Terminal Pro-Brain Natriuretic Peptide in Healthy Individuals. Clinical Chemistry. https://doi.org/10.1373/49.9.1554
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.